|
|
Volumn 12, Issue 2, 2004, Pages 164-180
|
|
The regulation of gene therapy research in competent adult patients, today and tomorrow: implications of EU Directive 2001/20/EC.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADVISORY COMMITTEE;
ARTICLE;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
COMPREHENSION;
DEPARTMENT OF HEALTH (GREAT BRITAIN);
EUROPEAN UNION;
GENE THERAPY;
GENE THERAPY ADVISORY COMMITTEE (GREAT BRITAIN);
GENERAL MEDICAL COUNCIL (GREAT BRITAIN);
GENETICS AND REPRODUCTION;
HUMAN;
HUMAN EXPERIMENT;
INFORMED CONSENT;
INTERNATIONAL COOPERATION;
INTERPERSONAL COMMUNICATION;
LEGAL APPROACH;
LEGAL ASPECT;
MEDICAL RESEARCH COUNCIL (GREAT BRITAIN);
PHASE 1 CLINICAL TRIAL;
PRACTICE GUIDELINE;
PROFESSIONAL STANDARD;
RISK;
ROYAL COLLEGE OF PHYSICIANS;
UNITED KINGDOM;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
DEPARTMENT OF HEALTH (GREAT BRITAIN);
GENE THERAPY ADVISORY COMMITTEE (GREAT BRITAIN);
GENERAL MEDICAL COUNCIL (GREAT BRITAIN);
GENETICS AND REPRODUCTION;
LEGAL APPROACH;
MEDICAL RESEARCH COUNCIL (GREAT BRITAIN);
ROYAL COLLEGE OF PHYSICIANS;
ADVISORY COMMITTEES;
CLINICAL TRIALS, PHASE I;
COMPREHENSION;
DISCLOSURE;
ETHICS COMMITTEES, RESEARCH;
EUROPEAN UNION;
GENE THERAPY;
GREAT BRITAIN;
GUIDELINES;
HUMANS;
INFORMED CONSENT;
INTERNATIONALITY;
NONTHERAPEUTIC HUMAN EXPERIMENTATION;
RISK;
|
|
EID: 33748463196
PISSN: 09670742
EISSN: None
Source Type: Journal
DOI: 10.1093/medlaw/12.2.164 Document Type: Article |
|
Times cited : (12)
|
|
References (0)
|
